Megan Harper
Roland Berger’s latest report, “The Future of Health 6: The AI (R)evolution in Health”, explores how artificial intelligence and generative AI are transforming healthcare. Based on insights from 100 senior executives across 12 countries, the report highlights evolving strategies, infrastructure gaps, and collaborative pathways to drive innovation responsibly across the healthcare ecosystem.
AI Drives Healthcare Evolution, Not Disruption
- 52% of hospitals now partially use AI in diagnostics, with 32% piloting new AI solutions.
- AI adoption focuses on gradual improvements to diagnostics, care quality, and operational workflows.
Transforming the Patient Journey
- AI enables personalized treatment plans and hybrid care models that blend physical and digital services.
- Applications include predictive analytics, AI-assisted imaging, and patient flow optimization.
Accelerating R&D and Drug Development
- 68% of pharma companies are using AI to reduce costs and time-to-market in drug discovery and clinical trials.
- Generative AI tools are increasingly used to simulate compound behavior and optimize trial design.
Readiness Gap and Strategic Collaborations
- Only 29% of healthcare providers feel AI-ready for competitive advantage.
- 87% prefer to partner with large tech companies to fill technical and data infrastructure gaps.
Why This Report Matters
- Offers practical frameworks for applying AI across the healthcare value chain.
- Highlights five strategic priorities: customer focus, workforce readiness, scalable IT, pilot deployment, and ecosystem partnerships.
- Serves as a roadmap for responsibly scaling AI innovation across clinical and operational domains.
“AI is not a healthcare revolution—it’s an evolution. But one that’s accelerating fast.”— Roland Berger, The Future of Health 6
Explore how other organizations are driving AI-enabled care in our exclusive interview with Mana.bio.
For further details, visit: https://www.rolandberger.com
